DEXCOM, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- DEXCOM, INC. payments for repurchase of common stock for the quarter ending 2025-12-31 was $312.80M.
- DEXCOM, INC. payments for repurchase of common stock for the quarter ending 2025-09-30 was $187.20M, a 75.04% decline year-over-year.
- DEXCOM, INC. payments for repurchase of common stock for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- DEXCOM, INC. payments for repurchase of common stock for the quarter ending 2024-09-30 was $750.00M.
- DEXCOM, INC. payments for repurchase of common stock for fiscal 2025 was $500.00M, a 33.33% decline from fiscal 2024.
- DEXCOM, INC. payments for repurchase of common stock for fiscal 2024 was $750.00M, a 8.90% increase from fiscal 2023.
- DEXCOM, INC. payments for repurchase of common stock for fiscal 2023 was $688.70M, a 23.49% increase from fiscal 2022.
- DEXCOM, INC. payments for repurchase of common stock for fiscal 2022 was $557.70M.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2025-12-31 | $312.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $500.00M 10-K · filed 2026-02-12 |
| 2025-09-30 | $187.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $750.00M 10-K · filed 2026-02-12 |
| 2024-09-30 | $750.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | |
| 2023-12-31 | $500.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $688.70M 10-K · filed 2026-02-12 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $557.70M 10-K · filed 2025-02-18 |
| 2022-09-30 | $557.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | $0.00 10-K · filed 2024-02-08 |
| 2020-12-31 | $0.00 10-K · filed 2023-02-09 | |
| 2019-12-31 | $0.00 10-K · filed 2021-02-11 | |
| 2018-12-31 | $100.00M 10-K · filed 2021-02-11 | |
| 2017-12-31 | $0.00 10-K · filed 2020-02-13 | |
| 2016-12-31 | $0.00 10-K · filed 2019-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |